Blood Plasma Freezer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Manual Defrost, Automatic Defrost, and Others), By Application (Hospitals, Laboratory, and Others), By Region and Competition, 2020-2030F

Market Overview

Global Blood Plasma Freezer Market was valued at USD 561.12 Million in 2024 and is expected to reach USD 758.96 Million by 2030 with a CAGR of 5.12% during the forecast period. The global blood plasma freezer market is primarily driven by the increasing demand for plasma-derived therapies and the growing need for efficient plasma storage solutions. As the prevalence of chronic diseases such as haemophilia, autoimmune disorders, and immunodeficiencies rises, the need for proper storage and preservation of blood plasma has become critical. Plasma freezers are essential for maintaining the integrity of plasma proteins during storage, ensuring their efficacy for medical use. Advancements in freezer technology, such as improved temperature control, energy efficiency, and faster freezing capabilities, are also contributing to market growth. The expanding healthcare infrastructure, particularly in emerging markets, along with the rise in plasma collection centers, is further boosting the demand for specialized blood plasma freezers.

Key Market Drivers

Increasing Demand for Plasma-Derived Therapies

The global demand for plasma-derived therapies has witnessed significant growth over the past few years, and this trend is expected to continue in the coming decades. Plasma-derived therapies are essential for treating a range of chronic and complex diseases, including hemophilia, immune deficiencies, autoimmune diseases, and genetic disorders. For instance, immunoglobulins are used to treat immune system deficiencies, while albumin is crucial in managing liver disease, burns, and shock. As more people around the world are diagnosed with conditions requiring plasma-based treatments, there is a rising need for robust plasma storage systems that ensure the plasma remains viable for medical use. In June 2024, the All India Institute of Medical Sciences (AIIMS) conducted India’s first and the eighth global fetal blood transfusion procedure to save a child with a rare disorder. The procedure was necessary due to complications arising from the incompatibility between the mother’s and the baby’s red blood cells. The mother tested negative for the Rh 17 antigen, a rare condition, which led to the baby developing anaemia. Thanks to the successful intervention, doctors were able to save both the mother and the baby.

Blood plasma freezers play a critical role in maintaining the integrity of plasma, which is a delicate biological substance. The freezing process helps preserve the proteins and other components of plasma that are crucial for therapeutic use. These freezers provide the necessary temperature control and stability required to store plasma for extended periods before it is fractionated into specific therapeutic products. As plasma-derived therapies continue to become a cornerstone of modern medicine, especially for rare and chronic diseases, the demand for blood plasma freezers to store these materials safely is growing. With the increasing number of patients requiring these therapies, healthcare facilities and plasma centers are ramping up their plasma storage capabilities, further boosting the blood plasma freezer market.

Rising Prevalence of Chronic and Rare Diseases

The increasing prevalence of chronic diseases and rare conditions is significantly driving the demand for plasma-derived therapies, thereby pushing the need for reliable plasma storage solutions. Diseases such as hemophilia, rheumatoid arthritis, multiple sclerosis, and primary immunodeficiencies often require patients to receive regular treatments with plasma-derived products. The global aging population, which is more susceptible to these conditions, is contributing to a growing pool of patients needing these therapies. The increasing number of patients diagnosed with autoimmune and blood disorders further drives the demand for plasma-based treatments. In the European Union, it is estimated that between 27 and 36 million people are living with a rare disease. Currently, there are between 6,000 and 8,000 distinct rare diseases, with some affecting only a few patients, while others can impact as many as 245,000 individuals. Approximately 80% of rare diseases are of genetic origin, and 70% of these conditions begin during childhood.

As these diseases often require lifelong management, the demand for immunoglobulins (IVIG), albumin, and coagulation factors is expected to continue to rise. This, in turn, will increase the need for high-quality plasma storage solutions to ensure that plasma retains its therapeutic properties before it is processed into specific medical products. As the healthcare sector adapts to the growing prevalence of such conditions, the requirement for blood plasma freezers that maintain the integrity of plasma is becoming more critical. The increasing patient population, coupled with rising healthcare awareness, is driving market demand for advanced storage solutions in medical facilities, research institutions, and plasma collection centers worldwide.

Rising Awareness About Plasma Donation and Its Benefits

Plasma donation awareness has seen substantial growth in recent years, and this is playing a crucial role in increasing the availability of plasma for medical use. Various health campaigns and initiatives by governments, non-profit organizations, and private companies have been aimed at educating the public about the importance of plasma donation. Plasma is an invaluable resource for producing life-saving therapies, and as more people recognize its significance, the number of donors is rising. In October 2024, the Ram Manohar Lohia Institute of Medical Sciences (RMLIMS) held a candlelight rally to raise awareness about the importance of blood donation. The State Blood Transfusion Council highlighted the significance of regular blood donation during the event.

The increase in plasma donations has directly contributed to the growth of plasma collection centers and, consequently, the need for blood plasma freezers. As more centers are established to process and store donated plasma, there is an increasing demand for reliable and efficient freezing systems to ensure plasma quality is maintained. The rise in plasma donation has increased the volume of plasma available for fractionation into therapeutic products. Plasma freezers play a vital role in ensuring that donated plasma remains viable for future therapeutic use, supporting the rising demand for plasma-derived treatments.

Growth of the Healthcare Infrastructure in Emerging Markets

Emerging markets, particularly in Asia-Pacific, South America, and Africa, are experiencing rapid growth in their healthcare infrastructure. As these regions continue to improve their healthcare systems, the demand for high-quality medical equipment, including blood plasma freezers, is on the rise. As more countries in these regions build and expand plasma collection centers and healthcare facilities, they require advanced plasma storage solutions to accommodate the growing volume of plasma donations.

These regions are also increasingly recognizing the importance of plasma-derived therapies in addressing chronic and complex medical conditions. With improving healthcare access, expanding donor bases, and better regulatory frameworks, the need for efficient plasma storage is set to increase. The global trend of improving healthcare infrastructure in these regions presents a significant growth opportunity for the blood plasma freezer market, as it drives both the expansion of plasma collection centers and the need for better storage technologies.

Increased Investment in Biopharmaceutical R&D

Increased investment in biopharmaceutical research and development (R&D) is driving the blood plasma freezer market. As pharmaceutical companies explore new applications for plasma-derived therapies, there is an increasing demand for plasma fractionation and storage capabilities. New therapeutic indications for plasma-derived proteins, such as in the treatment of genetic disorders, cancer, and neurological conditions, require more plasma to be processed and stored. This necessitates the adoption of advanced freezing technology to preserve plasma during the development and manufacturing phases.

The rising investments in R&D by both private companies and government-backed organizations, focused on discovering new therapeutic uses for plasma-derived products, further fuels the market for blood plasma freezers. As biopharmaceutical companies push the boundaries of what can be treated with plasma, ensuring safe and reliable storage becomes increasingly important to meet the needs of scientific progress.

Download Free Sample Report

Key Market Challenges

High Capital and Operational Costs

One of the most significant challenges for the global blood plasma freezer market is the high capital and operational costs associated with purchasing and maintaining plasma freezers. These specialized units require significant upfront investment, and their operation is often energy-intensive, resulting in higher ongoing maintenance and operational costs. The initial cost for installing and maintaining a state-of-the-art blood plasma freezer, equipped with advanced features like precise temperature regulation, remote monitoring, and energy efficiency, can be prohibitive, especially for smaller plasma collection centers or healthcare facilities in developing markets.

In addition to high initial investment, operational costs, such as electricity consumption and maintenance of advanced technologies, also contribute to the overall expense. For instance, plasma freezers that utilize advanced refrigerants, sensors, and monitoring systems may have higher maintenance needs, requiring specialized personnel or external service providers. These high costs can limit the widespread adoption of blood plasma freezers, especially in emerging economies where healthcare infrastructure is still developing.

Temperature Control and Stability

Maintaining precise temperature control is critical for the safe storage of plasma, but achieving and maintaining the required conditions over extended periods can be challenging. Blood plasma requires a consistent, stable temperature, typically ranging from -30°C to -40°C, to ensure its integrity and therapeutic efficacy. Even minor fluctuations in temperature can cause protein degradation, which would render the plasma unsuitable for therapeutic use. This makes the reliability of temperature control systems a crucial factor for plasma freezers.

Failure in temperature regulation due to mechanical failure, electrical issues, or external environmental factors can lead to plasma spoilage and potential waste of a valuable medical resource. Even with advanced features like real-time monitoring and automated alerts, the risk of a freezer malfunction still poses a challenge for ensuring the long-term safety and viability of plasma. The logistical challenge of ensuring proper temperature control during the transportation of plasma (from collection centers to fractionation facilities or hospitals) further complicates the overall storage and handling process.

Key Market Trends

Expansion of Plasma Collection Centers

One of the most significant drivers of the blood plasma freezer market is the global expansion of plasma collection centers. As the demand for plasma-derived therapies rises, the need for a consistent and high-quality plasma supply has become a focal point for healthcare providers worldwide. To meet this demand, there has been an increase in the number of plasma donation centers. In countries like the United States, Germany, China, and India, plasma donation centers are becoming more common, often supported by both government initiatives and private enterprises. Plasma centers facilitate the collection of large quantities of plasma, which can be further processed and fractionated into valuable therapeutic products. In September 2024, Grifols, a global healthcare company, partnered with French telecom giant Orange to establish a sustainable supply of vital therapeutics for life-threatening diseases in Egypt. Orange Business, the enterprise division of Orange Group, has successfully completed the first phase of a new data center and communication infrastructure in Cairo, aimed at supporting Grifols Egypt for Plasma Derivatives (GEPD). This collaboration is designed to enhance healthcare capabilities in the country by ensuring a reliable supply of essential plasma-derived products.

However, collecting plasma is only the first step. To maintain the efficacy of the plasma and ensure it is safe for future therapeutic use, it needs to be stored under optimal conditions immediately after collection. This is where blood plasma freezers come into play. These freezers are designed to keep plasma at the precise temperatures required to prevent degradation of proteins and other critical components. As more plasma collection centers are established globally, especially in emerging markets, the demand for reliable and efficient plasma storage solutions is also increasing. This, in turn, propels the demand for advanced blood plasma freezers. As more public health organizations encourage plasma donation and raise awareness about its therapeutic potential, the need for efficient storage solutions to accommodate the growing volume of plasma is expected to increase.

Technological Advancements in Freezer Technology

Technological innovations in freezer design and performance have made blood plasma freezers more efficient, reliable, and cost-effective, thereby driving their adoption in hospitals, plasma centers, and research institutions. Over the past few years, blood plasma freezers have evolved from simple cooling units to highly sophisticated machines with advanced features. Key technological advancements include the development of more energy-efficient systems, precise temperature regulation, faster freezing capabilities, and remote monitoring features that ensure consistent and reliable plasma storage.

Modern plasma freezers are equipped with sensors that maintain temperature stability, which is crucial for preventing the degradation of plasma proteins. Smart technologies, such as automated temperature alerts, allow users to monitor freezer performance in real-time and receive notifications if the temperature falls outside the required range. This added layer of control reduces the risks of plasma loss due to temperature fluctuations. Innovations in insulation materials have made plasma freezers more energy-efficient, helping healthcare facilities and plasma centers lower their operating costs while maintaining high standards of storage quality.

These technological advancements are particularly important in ensuring the safe storage of plasma, especially when it is being transported across long distances or stored for extended periods. As manufacturers continue to enhance plasma freezer designs, the overall market for blood plasma freezers is expected to grow, with a focus on improving both functionality and energy efficiency.

Segmental Insights

Application Insights

Based on the Application segment, hospitals are the dominant sector compared to laboratories, primarily due to the large-scale demand for blood plasma storage, its use in patient treatment, and the growing need for advanced storage solutions in healthcare facilities. While both hospitals and laboratories play critical roles in the healthcare ecosystem, hospitals have a more extensive and immediate need for plasma storage, making them the key drivers of the market’s growth.

Hospitals, especially those with specialized departments like blood banks, transfusion medicine, and hematology, require significant volumes of stored plasma to treat patients with a variety of conditions, including bleeding disorders, immune deficiencies, and burn victims. The demand for plasma-derived therapies such as albumin, immunoglobulins, and clotting factor concentrates is constantly rising, driving the need for reliable and large-scale blood plasma storage solutions. As hospitals are at the forefront of patient care, they play a central role in the blood plasma freezer market, with an ever-growing need for plasma storage that meets stringent regulatory standards and ensures plasma integrity.

In hospitals, blood plasma is often stored for emergency transfusions, long-term treatments, and research purposes. Plasma is a critical resource for patients who require replacement therapy for clotting factors, immunoglobulins, or albumin for conditions such as hemophilia, immune disorders, and liver failure. This creates a steady demand for reliable and efficient plasma freezers that can preserve plasma at the necessary low temperatures, typically ranging between -30°C and -40°C, to maintain its efficacy for therapeutic use. The size and complexity of hospitals often require a larger and more sophisticated infrastructure for plasma storage, which directly contributes to the dominance of hospitals in this market.

Download Free Sample Report

Regional Insights

North America stand as the dominant region, primarily due to its advanced healthcare infrastructure, high demand for plasma-derived therapies, stringent regulatory frameworks, and significant investments in medical research. While other regions such as Europe, Asia Pacific, and the Middle East & Africa are also growing markets, North America leads in terms of both market share and technological advancements in blood plasma storage.

North America, particularly the United States, is the largest market for blood plasma freezers, driven by the robust healthcare system, widespread plasma collection and donation programs, and increasing demand for plasma-derived therapies. The U.S. is home to numerous plasma collection centers and biopharmaceutical companies that specialize in developing treatments from blood plasma, such as immunoglobulins, albumin, and clotting factor concentrates. These therapies are essential for treating patients with conditions like hemophilia, immune deficiencies, and burns, all of which are becoming more prevalent, particularly with the aging population.

As the demand for plasma-based treatments continues to rise, so does the need for reliable and efficient plasma storage solutions. The large-scale healthcare facilities in North America require high-capacity blood plasma freezers to store plasma for therapeutic use, ensuring that it remains viable for use in life-saving treatments. North America hospitals and blood banks are often equipped with state-of-the-art storage equipment to comply with strict standards for temperature control and regulatory compliance.

Recent Developments

• In September 2024, Redcliffe Labs, a network of diagnostic centers and labs in India, announced plans to raise USD 42 million in Series C funding. The funding includes USD 20 million from IFU, Denmark’s Investment Fund, USD 15 million from the investor LeapFrog, with the remaining amount contributed by shareholders such as HealthQuad and Spark Growth Venture. The funds will be utilized to expand the company’s network by opening additional labs and collection centers, as well as establishing a home collection network.
• In February 2024, Helmer Scientific, a leader in providing refrigerators and freezers for hospital labs, pharmacies, clinics, and research facilities, announced that its GX Solutions Ultra-Low Temperature Freezer has earned the ENERGY STAR certification and is also recognized by the U.S. Environmental Protection Agency (EPA).
• In April 2024, Thermo Fisher Scientific unveiled a new range of high-performance ultra-low temperature (ULT) freezers. This medical device is designed to store and preserve blood and blood components, enhancing workflow efficiency across various laboratory environments.
• In January 2024, Haier Biomedical launched its inverter ultra-low temperature freezer, known for its exceptional performance, energy efficiency, and eco-friendly design. These freezers provide comprehensive protection for sample storage, making them perfect for blood stations, hospitals, CDCs, laboratories, and research institutions.

Key Market Players

• Haier Inc.
• PHC Holdings Corporation 
• Thermo Fisher Scientific, Inc.
• Dometic Group AB
• Helmer Scientific Inc.
• Lec Medical (Glen Dimplex Home Appliances Limited)
• Changhong Meiling Co.,Ltd.
• Felix Storch, Inc.
• Follett Corporation
• Jointlab S.r.l.

Report Scope:

In this report, the Global Blood Plasma Freezer Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Blood Plasma Freezer Market, By Type:

o   Manual Defrost

o   Automatic Defrost

o   Others

• Blood Plasma Freezer Market, By Application:

o   Hospitals

o   Laboratory

o   Others

• Blood Plasma Freezer Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Plasma Freezer Market.

Available Customizations:

Global Blood Plasma Freezer market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).